Global registry for genetic obesity

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The International Genetic Obesity Registry is an observational program that gathers clinical, genetic, and routine outpatient data from patients with monogenic or early-onset severe obesity. Participants provide consent and allow their medical records, genetic test results, and follow-up information to be entered into a centralized database. No experimental treatments are given; the registry documents natural history, comorbidities, and responses to standard therapies. The aggregated data aim to support research, inform clinical care, and help tailor management to specific genetic subtypes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with

  * genetically confirmed genetic obesity (ACMG classification 3-5, associated with obesity) and/or
  * early onset severe obesity (BMI ≥ 120% 95th percentile or ≥ 35 kg/m2 before 5 years of age) if genetic testing was performed
* Capable of understanding the aims of the protocol and to provide informed consent (for children and chronically incapacitated individuals, consent is given by their legal guardians)

Exclusion Criteria:

* Not capable of understanding the aims of the protocol and to provide informed consent

Where it's running

• Ulm University Clinic
  Ulm, Germany Recruiting

Study contacts

• Study coordinator: Julia von Schnurbein, PD Dr.
• Email: julia.vonschnurbein@uniklinik-ulm.de
• Phone: 0049 731 500 57401

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Glucose levels during a 6 km loaded march

  We will test how blood sugar changes during a 6 km march carrying 15 kg of equipment in healthy soldiers using continuous glucose monitors.

  Recruiting University of Ulm · Ulm · NCT07543705

• Parental metabolism's imprint on the fetal epigenome in gestational diabetes

  We will see if parents' metabolism during pregnancy is linked to epigenetic changes in the fetus in pregnancies with and without gestational diabetes.

  Recruiting University of Ulm · Ulm, Baden-Wurttemberg · NCT07436195

• How changing thyroid hormone levels affects blood sugar, lipids, and energy use

  This trial will test whether raising or lowering thyroid hormones in people with newly diagnosed Graves' disease or thyroid cancer changes blood sugar, insulin, and lipid metabolism using oral glucose tolerance tests.

  Recruiting University of Ulm · Ulm, Baden-Wurttemberg · NCT07410637

• Once-weekly semaglutide for weight loss in adolescents with monogenic obesity

  This study tests whether once-weekly semaglutide 2.4 mg together with a reduced-calorie diet and increased activity helps adolescents with monogenic obesity lose weight, reduce hunger, and improve quality of life over 68 weeks.

  Recruiting University of Ulm · Paris and 6 other locations · NCT07302802

• Immunoadsorption treatment for chronic inflammatory demyelinating polyneuropathy

  This observational study will try immunoadsorption as a next-step treatment for adults with CIDP who do not respond well to IVIg or methylprednisolone.

  Recruiting University of Ulm · Ulm, Baden-Wurttemberg · NCT07154524

• Investigating how brain signals affect organ function in health and disease

  This study tests how blocking brain signals with atropine during a glucose test affects organ function in healthy people and those at risk for metabolic disorders, while also looking at differences between men and women.

  Recruiting University of Ulm · Ulm · NCT06912048

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.